E

Emcure Pharmaceuticals Ltd
NSE:EMCURE

Watchlist Manager
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Watchlist
Price: 1 314.15 INR 2.36% Market Closed
Market Cap: 248.5B INR
Have any thoughts about
Emcure Pharmaceuticals Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

21.4
Current
22.1
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
21.4
=
Enterprise Value
262.8B INR
/
EBITDA
12.3B INR
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.1
2-Years Forward
EV/EBITDA
15
3-Years Forward
EV/EBITDA
13

See Also

Discover More